Turnover
≈ €170,000 estimated
The micro format states no turnover.
ACP-PHARMA
Lifetime
1 annual account with figurespeak €34,469 (2025)
€34,469
peak €24,290 (2025)
€24,290
peak €29,290 (2025)
€29,290
€18,728
Board1 name since 2025
1 director
Documentsfilings and deeds
24-09-202655 days late
2025micro format
Incorporation 15-011 establishment registeredFirst year with figures
Key points
from the 2025 annual accountsStarting capital
€5,000 10 shares
2025 accounts filed 55 days after the deadline
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 11,278 companies had the same profile as ACP-PHARMA has now. Each dot stands for 29 companies, two years later.
96.6%
were still trading
2.6%
stopped another way
0.7%
went bankrupt
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 11,278 companies, not a prediction for ACP-PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1018630058
Incorporation
Founding capital of €5,000, 10 shares · Founder: · Appointment: (director) · published on 15-01-2025 · Gazette deed
First establishment
Domentstraat 51, Affligem
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| ACP-PHARMA Affligem | €48,017 | €34,469 | 61.0% | - |
| FLK. SOCIETY Namur | €44,600 | €32,964 | 64.1% | - |
| 9 INTO C Dendermonde | €43,215 | €29,890 | 46.1% | - |
| far.mar.sie. Hasselt | €48,660 | €29,177 | 50.5% | - |
| Sarah Spruyt Pharma & Care Mechelen | €58,307 | €38,504 | 51.7% | - |
| PHARMACIE DE LEERNES Châtelet | €41,076 | €29,035 | 54.5% | - |
| Pharmayat Auderghem | €60,904 | €35,726 | 49.3% | - |
These companies have the same main activity as ACP-PHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €41,100 and €60,900, founded between 2024 and 2025.
Official details
Source: KBO- Status
- Active since 13-01-2025Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730and 3 others
- Establishment unit
- 2.369.266.8671790 Affligem, since 13-01-2025
- Financial year end
- 31 December
- Peppol
- Reachable since 26-02-2025
Insights on ACP-PHARMA
The 2025 annual accounts show equity of €29,290 and a net result of €24,290. Its solvency ranks better than 73% of 25,237 sector peers (NACE 47, financial year 2025).
The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about ACP-PHARMA
- What is the company number of ACP-PHARMA?
- The company number of ACP-PHARMA is 1018.630.058. The VAT number is the same number with BE in front: BE 1018.630.058.
- Where is ACP-PHARMA based?
- The registered office is at Domentstraat 51, 1790 Affligem.Company details
- What does ACP-PHARMA do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of ACP-PHARMA?
- ACP-PHARMA is a private limited company (BV).
- When was ACP-PHARMA founded?
- ACP-PHARMA was founded on 13-01-2025.
- Is ACP-PHARMA still active?
- Yes, ACP-PHARMA is an active enterprise in the KBO register.
- What is the turnover of ACP-PHARMA?
- The turnover in financial year 2025 is ≈ €170,000. This figure is estimated from the gross margin of €34,469 and 51 comparable companies (NACE 477). It probably lies between €89,000 and €300,000.Financials
- Is ACP-PHARMA profitable?
- In financial year 2025, ACP-PHARMA made a profit of €24,290.
- Where can I find the annual accounts of ACP-PHARMA?
- ACP-PHARMA filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark Estimate what this company is worth.Value indication
See how customers, suppliers and banks see your own company and what to improve first.